MET and esophageal squamous cell carcinoma: The present study was designed to evaluate the impact of MET phosphorylation on the biological behavior of the ESCC cell line KYSE-30 through introducing and investigating the efficacy of some novel heterocyclic inhibitor molecules against MET kinase activity.